This is an HTML version of an attachment to the Freedom of Information request 'Meetings with the pharmaceutical industry since December 1st 2019'.



Ref. Ares(2020)2433183 - 07/05/2020
Meeting with EFPIA on future priorities of EU trade policy 
Meeting date and place 
Meeting held on 29/01/2020 11:30 in Charlemagne 
Participating organisation(s) & representative(s) 
 - European Federation of Pharmaceutical Industries and Associations
ParticipantRequester
[Art. 4.1 (b)]
[Art. 4.1 (b)]
(TRN: 38526121292-88) 
Contact
[Art. 4.1 (b)]
- - European Federation of Pharmaceutical Industries and Associations (TRN:
Participant
38526121292-88) 
- - European Federation of Pharmaceutical Industries and Associations (TRN:
[Art. 4.1 (b)]
Participant
38526121292-88) 
[Art. 4.1 (b)]
[Art. 4.1 (b)]
 - European Federation of Pharmaceutical Industries
Participant
and Associations (TRN: 38526121292-88) 
Main issues discussed 
EFPIA made the following points:
Priority countries for EFPIA are the US, China, Turkey, Russia, Japan (and Switzerland). 
In addition to their general IP concerns (they were very appreciative of our last IP report which well reflected their input), they are
currently worried by US - and the possibility that the sector could be hit by tariffs from either side.
[Art. 4.2 first indent]
They expect EU’s trade policy to:
Project an open and innovation friendly image around the world. They fear that the turn in international stability may lead to a
protectionist trade policy. 
Defend IP. 
Project EU standards globally
Be able to enforce properly trade agreements (strong interest/high expectation on CTEO)
They enquired when the new communication on trade and investment policy would be issued and how they could be involved in the
process.
Brexit: Very interested, in particular in MRA in their sector. 
On Brexit, [Art. 4.1 (b)]
 clarified that a new structure was being set up as negotiations will start and that  Unit G1 was no longer in
charge of BREXIT related issues (referring to  [Art. 4.1 (b)]
). She then presented the new priorities of EU trade policy that are
emerging and explained that we are at anytime open for contributions form stakeholders, especially now that we are starting a new
institutional cycle. 
Directorate or unit 
TRADE G/1 
Internal participants 
[Art. 4.1 (b)]
TRADE  G/1  [Art. 4.1 (b)]
@ec.europa.eu) 
Participant
[Art. 4.1 (b)]
TRADE  G/1  [Art. 4.1 (b)]
@ec.europa.eu) 
ParticipantNotetaker
[Art. 4.1 (b)]
TRADE  G/3 
@ec.europa.eu) 
[Art. 4.1 (b)]
Participant
Author(s) of minutes 
[Art. 4.1 (b)]
Validator and validation date 
[Art. 4.1 (b)]
 validated the minutes on 13/02/2020 13:34 
Minutes generated by EMT (Id:TRADE/1393)
Page 1 of 1